skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I bought Kelso two weeks ago and it has now dropped 17%. Should I be worried? Has something changed with the company?
Read Answer Asked by Carla on January 15, 2015
Q: Hello, Peter
Today qst(questor technology) dropped 12%,any news, if no bad news, do you think it is a good time to buy if i want to hold for few years?
Thank you so much for your help!
Yingzi
Read Answer Asked by Yingzi on January 14, 2015
Q: Do you know why ET is down big today. How would you rank these companies in terms of growth potential combined with safety:

ESL, ET, BEP.UN, CXR, KLS
Read Answer Asked by Imtiaz on January 13, 2015
Q: Hi Guys looking for some ideas for my RRSP and TFSA contributions for the year. Obviously without knowing my other holdings this is a little more difficult exercise for you, looking for max growth, dividend not required and 20 years until retirement. Based on the discussion from 5i I'm considering CXI, DHX and/or QST. Any thoughts? Thank-you.
Read Answer Asked by Chris on January 12, 2015
Q: Happy New Year Team!!
I am looking at putting together a new TFSA portfolio of ETFs with the following considerations:
-$36500 to invest.
-time horizon 10 years +.
-target 10% growth per year.
-goal of a diversified mix with exposure in and outside of Canada.

Question: Which ETF's in which categories would you recommend? (ie. Canadian, US, International, Sectors, Bonds, Dividends, etc.)
Thank you, I look forward to your reply.
Read Answer Asked by Eric on January 12, 2015
Q: I've been searching for relatively cheap canadian pharma stocks that have postive cashflow and earnings growth. I recently came across CRH Medical, a recent recommendation of J.Donville. After accounting for the recent aquisition (trailing earning, some dilution, and debt), to me, it still appears quite cheap relative to the sector. I realize there is some execution risk, and now a fair bit of debt, but it seems reasonable. How do you assess this company and compare it to other small/growthy names in the sector? I currently have a half position in CRH and I am thinking about doubling down. I also own PHM and CPH in the sector but they don't look as cheap anymore. Thanks.
Read Answer Asked by Scott on January 07, 2015
Q: Would you please give me a quick rating for the following companies: Concordia (CXR), DH Corp (DH), Boyd Fund (BYD.UN) and CGI Group (GIB.A) -- in the A, B, C rating that 5I does. I realize a full analysis is impossible, but just wondered in a "wish list" of descending companies, which would you choose for a post-Christmas present to yourself, for growth in 2015? Thanks.


Read Answer Asked by Sylvia on December 30, 2014
Q: Hello Peter & Co,
Hope you had a Merry Christmas and wish you a Happy New Year.
12% of my portfolio is in Health/Pharma which comprises CCT, CPH, CXR, GUD, RX and XHC; is there a point to adding CRH which is similar to RX?
Thanks,
Tony
Read Answer Asked by Antoine on December 30, 2014
Q: Can I get your views on this company at present stock price. Does not want to seem to pull back any. P/E seems high at 48x and P/B is at 18. Is this considered high for small cap?

thanks
Read Answer Asked by pietro on December 29, 2014
Q: Hello Peter and team,

I am getting ready to make my 2015 TFSA contribution on Jan 2nd, and with some cash in that account I would like to invest in one or two growthy stocks. What are your top 5 suggestions for a TFSA at this time (holding period is 3 years minimum).

Also can you list your top 3 TFSA suggestions in the Information Technology and the Health Care sectors.

Please rank your choices highest to lowest.

Happy New Year,

Paul J.

Read Answer Asked by Paul on December 29, 2014
Q: I was disappointed to read this week that the “Growth Portfolio” won’t be available until March. I need to be very aggressive for a while. I currently hold: atd.b, ccl.b, stn, gil, aya, which I suspect will be candidates for this portfolio. Could you name a couple of others that you are considering. Thanks.
Read Answer Asked by Bill on December 22, 2014
Q: Hello Peter
I would like to diversify into the health care and pharma industry. I could not find in the database any companies that have a minimum of a B rating. Are there any health care and pharma companies that you would recommend with at least a B rating. Would an ETF be better? I would like to hold it in my rsp and have a 3-5 yr time frame to hold.

Thank you
Read Answer Asked by pietro on December 16, 2014
Q: I have accumulated Canadian biotech/pharma companies RX, CPH, CXR, MSL, NRI and NHC with a hope that some of them might be taken over by the others. Do you think there is a possibility of any of these companies buying the other. Who do you think will be the most probable target and who is the most likely acquirer. Thanks
Read Answer Asked by Imtiaz on December 15, 2014
Q: Hi Peter,

Would you give me your opinion on above stock please. I consider to start buying some now.
Thank you.
Albert
Read Answer Asked by ALBERT on December 04, 2014
Q: Some reasons for good equity market.Seasonality & 3rd year of mid term election indicate strong Nov to April period.Low interest rate.Increasing earnings growth. Please advise if it is time to invest now?.If so,please provide some appropriate "growth & dividend" stocks. Thanks a lot for your usual excellent advices & serices
Read Answer Asked by Peter on November 23, 2014
Q: In spite of the much improved 2015 Q1 operating results over 2014 Q1, LMP's stock price had dropped from its highs in August/September by some 40% by early November (although it has a major rally over the last week or so but still down significantly from its highs). Your comments on this company going forward would be much appreciated.

H.S.
Read Answer Asked by Harry on November 20, 2014
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!